DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and offers related lab services in outpatient dialysis centers, as well as outpatient, hospital inpatient, and home-based hemodialysis services. Its portfolio also includes clinical laboratories that perform routine tests for dialysis and physician-prescribed tests for end-stage renal disease (ESRD) patients. Additionally, DaVita provides management and administrative services to outpatient dialysis centers, integrated care and disease management services under risk-based arrangements, clinical research programs, physician services, comprehensive kidney care services, and a transplant software business.

DaVita Inc. is listed on the New York Stock Exchange (NYSE) under the ticker symbol DVA. The company trades in United States dollars (USD), as it is headquartered in the United States and its primary listing is on a U.S. exchange.

DaVita Inc. operates in the Healthcare sector, specifically within the Medical Care Facilities industry. This means the company is involved in providing medical care services in facility-based settings, primarily focusing on kidney dialysis treatment for patients with chronic kidney failure.

DaVita Inc. is headquartered in Denver, Colorado, United States. The company primarily serves the U.S. market, operating kidney dialysis centers and providing related services across the country. Its services include outpatient dialysis, hospital inpatient dialysis, home-based hemodialysis, and clinical laboratory services for ESRD patients.

DaVita generates revenue primarily by providing kidney dialysis services to patients with chronic kidney failure. The company operates outpatient dialysis centers where patients receive regular treatments, and it also offers home-based hemodialysis services. Additionally, DaVita earns income from its clinical laboratories that perform routine and physician-prescribed tests for dialysis patients. The company provides management and administrative services to other outpatient dialysis centers, as well as integrated care and disease management services under risk-based arrangements. Other revenue streams include clinical research programs, physician services, comprehensive kidney care services, and a transplant software business.